The evaluation of health technologies at a turning point: the commitment of clinical engineers


Leogrande: We are living in an optimal institutional and regulatory moment to relaunch the HTA, in close relation with the purchases and other professions

The evaluation of technologies to be acquired in healthcare realities, HTA (Health Technology Assessment) “is a key topic at our 2022 Conference for two reasons. The first refers to our competence and profession: in fact, we take care of Hta every day in the activity we carry out. The second reason is linked to the really important institutional moment we are living in “, are the words of Lorenzo Leogrande, president of the XXII National Conference Aiic, Italian Association of Clinical Engineers, which is currently being held in Riccione. This is a real “relaunch” of the importance of hypertension in the Italian health system, the one operated in the Aiic event, which highlights well-known issues and stimulates new scenarios: “Through Delegated Law 53/2021 – reminds Leogrande – the national legislation for the two regulations 745/2017 and 746/2017 relating to health products and in vitro devices.In this standard there will also be a part related to the strengthening of hypertension, especially with regard to That is why we wanted to address the issue in a direct confrontation with the purchasing centers, which deal with the purchase process on a daily basis ”.

Today, the link between Hta and purchasing is substantially absent because “purchasing centers – continues the president of the Aiic Conference – collect the needs of healthcare companies, group demand and, in innovation tenders, adopt allocation mechanisms. direct. Instead we we expect the dissemination of a culture of hypertension that is applied independently of methodologies and regulatory obligations. Then we must work so that the purchasing processes take into account, whenever possible, the assessments made. It is clear that this connection must be created from a common language. “

Since 2017, with the implementation of the HTA control room that clearly and precisely set out the process of purchasing new technologies, the model has had difficulty translating into practice. In fact, the functionality of a rational and structured model, sanctioned by a State-Regions agreement, of a control room – formed by the Ministry of Health, National Agencies (Agenas and Aifa) and representatives of regions – for production d’Hta. “Despite the halt of the pandemic years, the regions have used elements of the process and therefore a working group has been set up whose mission is to try to make this relationship more efficient,” he said. Americo Cicchetti, director of Altems, the School of Economics and Management of Health Systems. However, a relationship that needs to be stabilized, updated and relaunched.

As the experts involved in the debate at the Aiic event have pointed out, this is the case today The 2017 State-Regions Agreement, which defined the national HTA program, needs to be updated and subsequently provided for a periodic update to make it authorized and representative for all parties involved.. In addition, “resources and responsibility are needed – was the message proposed by Cicchetti – among the missing elements in this moving scenario, no doubt one refers to resources, because it has always been thought to develop the Assessment of Sanitary Technologies without investments and this is obviously slow. if not immobile the whole system “.

In conclusion, Lorenzo Leogrande stressed that Aiic not only “observes the whole HTA system from within, but also aims to be its driving force. We, as professionals and together with other professionals, know perfectly the current advantages and criticalities and we will be the protagonists of proposals and suggestions to national and regional decision-makers, so that we do not miss the opportunity offered by the Pnrr and recent regulations. authentic, ensuring sustainability and proper management “.

Print, PDF and email

Leave a Comment